StockTipsArenaBeta

BUY Divi's Laboratories Limited — Ashish Bahety, Profitmart Securities

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byAshish Bahety, Profitmart SecuritiesHorizon: NA (inferred Swing (≤2wk))27 Oct 2026via CNBC Awaaz.

Entry₹9,294Inferred
Target₹9,800
Total upside +5.44%
Stop loss₹9,000-3.16% risk
CMP₹9,408Just now
Active+1.23%+4.17%upside left 13d left
Follow Ashish Bahety for new calls(33% target hit, 228 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 2 other Swing calls on DIVISLABSee 119 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 27 Oct, 12:52 pm IST
3 supporting1 neutral2 opposing
Supports the BUY call (3)

2 advisors have active intraday BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·27 Oct · today

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·27 Oct · today

Divi's Laboratories shares in focus as weight loss drug receives EU panel backing

NewsCnbc-Tv18·19 Oct · 1w ago

(opens in new tab)
Neutral / worth noting (1)

Q2 FY27 results scheduled — board meets 07 Nov 2026

BSE · Board Meeting·In 11 days

(opens in new tab)
Weighs against the BUY call (2)

MACD below its signal line — bearish momentum

Technicals · macd·27 Oct · today

1 other SEBI-registered advisor has an active swing SELL call on this stock, issued in the last 14 days

Advisor consensus · same horizon·14 Oct · 2w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Ashish Bahety, Profitmart Securities

Every call and its outcome